ABBV AbbVie Inc

By Dave Sebastian

AbbVie Inc., Evolus Inc. and Medytox said they have settled all outstanding litigation, including the U.S. International Trade Commission case, regarding the sale of cosmetic injection Jeuveau among the companies.

The companies Friday said AbbVie and Medytox will release claims against Evolus related to the alleged misappropriation of Medytox's trade secrets. Evolus will also be able to continue commercializing Jeuveau in the U.S., and similar injection Nuceiva in other territories where Evolus has licensing rights, they added.

AbbVie and Medytox will get milestone and royalty payments from Evolus, the companies said.

Medytox's California court case against Evolus will be dismissed, the companies said.

Write to Dave Sebastian at dave.sebastian@wsj.com

(END) Dow Jones Newswires

February 19, 2021 09:47 ET (14:47 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.